Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
Information source: The George Institute
Information obtained from ClinicalTrials.gov on November 03, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: * Myocardial Infarction; Angina Pectoris; Cerebrovascular Accidents; Diabetes Mellitus
Intervention: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin (Drug); self-identification and self-referral for CVD risk (Behavioral); Health care worker screening of high risk through algorithm (Behavioral); Lifestyle change: theatre, talks, cooking class, walking (Behavioral)
Phase: Phase 4
Status: Recruiting
Sponsored by: The George Institute Official(s) and/or principal investigator(s): Bruce C Neal, Principal Investigator, Affiliation: The George Institute
Overall contact: Clara K Chow, MBBS, FRACP, Phone: + 61 2 9993 4566, Email: cchow@thegeorgeinstitute.org
Summary
This study will evaluate the effectiveness of a novel cardiovascular disease prevention
program designed for delivery through existing primary health care services in rural villages
in Andhra Pradesh.
The primary aim is to increase the number of high-risk individuals in the population that are
appropriately managed with proven, low-cost preventive interventions. The corresponding null
hypothesis is therefore that the prevention program will result in no change in the
proportion of high–risk individuals identified and treated in villages assigned to
intervention compared with those villages assigned to control.
Clinical Details
Official title: Evaluation of a Primary Health Care Intervention for the Prevention of Cardiovascular Disease in Rural Andhra Pradesh
Study design: Prevention, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study
Primary outcome: differences inthe proportion of high-risk individuals identified and the proportions managed with appropriate treatment of lifestyle modification advice and recommended pharmacological agents. These outcomes will be assessed via ongoing population surveys of randomly selected individuals and clinical record reviews.
Secondary outcome: the knowledge, attitudes and practices of non-physician health care workers and physicians relating to cardiovascular prevention.the knowledge attitudes and practices of the population about preventable conditions and actions taken to prevent non-communicable disease the risk factor levels of the population identified as high risk.
Detailed description:
STUDY TYPE This project is a community intervention study that will use a large-scale,
cluster-randomised design to compare the management of individuals at high cardiovascular
risk in villages assigned to receive the cardiovascular prevention program (intervention) and
villages assigned to continue usual practices (control). The definition of high-risk for
treatment is based on an established history of previous vascular disease –heart attack or
stroke- known hypertension or systolic blood pressure > 160mmHg, or the presence of other
risk factors such as smoking, high blood pressure, obesity, older age and family history
which combined would result in a very high level of risk.
INTERVENTION PROGRAM TO BE EVALUATED The program to be evaluated comprises: (1) simple
strategies designed to facilitate the opportunistic identification of high-risk individuals,
(2) clinical algorithms for the implementation of proven preventive interventions based on
World Health Organisation recommendations (3) a health promotion campaign designed to aid
self-identification and self-referral of high-risk people and (4) simple, structured
education programs to assist patients to comply with their treatment.
DATA COLLECTION Data to be collected will comprise an interviewer administered questionnaire
with demographic details, basic medical history, cardiovascular risk factors, previous
cardiovascular disease and any current treatments. This will be followed by a brief physical
examination including measurement of blood pressure, heart rate, weight, height, waist and
hip circumferences. Urine will be tested using a dipstick in all and all will have a fasting
blood glucose assay. Fasting venous blood samples will be collected for assay of
cholesterol, glucose and creatinine from a sample of 1,000.
Eligibility
Minimum age: 30 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age 30 years and above
- Personal history of heart attack or stroke
- Presence of other cardiovascular risk factors such as smoking, overweight, diabetes
Exclusion Criteria:
- Mental disability
- Not living in the Study area
Locations and Contacts
Clara K Chow, MBBS, FRACP, Phone: + 61 2 9993 4566, Email: cchow@thegeorgeinstitute.org
Byrraju Foundation Primary Healthcare Centres in rural West Godavari and East Godavari Dstricts, Bhimavaram, Andhra Pradesh, India; Recruiting Akshay Mishra, MBBS, MD, Phone: * 91 9866550489, Email: Akshay@byrrajufoundation.org Bruce C Neal, MBChB PhD, Principal Investigator Stephen W MacMahon, BScMA PhD, Principal Investigator Clara K Chow, MBBS FRACP, Principal Investigator Magnolia Cardona, MBBS MPH, Principal Investigator K Rama Raju, MBBS MS surg, Principal Investigator P Krishnam Raju, MBBS MD, Principal Investigator
Additional Information
A community-based cluster randomised trial for the prevention of cardiovascular disease based on (1) opportunistic screening of high-risk individuals, (2) management with proven therapies following a clinical algorithm, and (3) health promotion campaign
Starting date: December 2005
Ending date: June 2007
Last updated: October 10, 2006
|